Delivery Order SPE2DB22D2211-SPE2DB25FSCCE
- Not listed
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $3,097.28 by the Defense Logistics Agency on September 8, 2025, for the supply of Zonisade 100 mg/5 mL oral suspension in a 150 mL container. The contract is a firm fixed-price delivery order with an ultimate completion date of September 9, 2025, and will be performed at the vendor's corporate office in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation and represents a child contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Zonisade 100 mg/5 ml oral suspension in a 150 ml quantity, with a ceiling value of $6,846.22. This non-competitive delivery order represents a firm fixed price transaction with an ultimate completion date of August 8, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award was issued without a set-aside designation, indicating it...
- This federal contract award, valued at $11,573.30, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to deliver the medication Zonisade 100 mg/5 ml oral suspension in 150 ml bottles. This award is a delivery order under an Indefinite Delivery Contract (IDC) valued up to $999,999,999 with the DLA Troop Support Medical, which provides a wide range of medical commodities to support military treatment programs and facilities...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at approximately $7,958 to Amerisourcebergen Drug Corporation for Zonisade 100 mg/5 ml oral suspension. The contract has a period of performance from August 30, 2023 through August 31, 2023. Place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The delivery order was issued against an existing indefinite-delivery/indefinite-quantity contract vehicle...
- The federal contract award summarized here is for the delivery of the pharmaceutical product "ZONISADE 100 MG/5 ML ORAL SUSP 150ML" to the Defense Logistics Agency (DLA). The contract, valued at $4,354.19, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of September 15, 2023. The contract is not designated with any...
- The Defense Logistics Agency awarded a delivery order valued at $889.12 to Amerisourcebergen Drug Corp for the supply of 150ml bottles of the pharmaceutical product Zonisade 100mg/5ml oral suspension. As the prime contractor, Amerisourcebergen Drug Corp will deliver the specified medication to the Defense Logistics Agency from its facility located in Conshohocken, Pennsylvania under a firm fixed price contract scheduled to be completed by August 16, 2023. The parent company of...
- This delivery order from the Defense Logistics Agency awards Amerisourcebergen Drug Corp $1,487.31 to supply 150ml of the oral suspension Zonisade 100 mg/5 ml. As the parent company, Amerisourcebergen Corporation will perform under the contract through its Corporate Office location in Conshohocken, Pennsylvania. The firm fixed price contract has an anticipated completion date of October 18, 2023 and did not utilize any set aside designations in the award. The Defense Logistics Agency supports...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The contract is for the delivery of "ZONISADE 100 MG/5 ML ORAL SUSP 150ML", a pharmaceutical product, with a potential value of $2,155.73 and a completion date of February 29, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp, through its...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,930.33, is for the delivery of ZONISADE 100 MG/5 ML ORAL SUSP 150ML, a pharmaceutical product. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award, with an ID of SPE2DB22D3011|SPE2DB24FQ0NN, was granted to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $1,111.35 firm fixed price delivery order is for the supply of the medication Zonisade 100 mg/5 ml oral suspension in 150 ml bottles. The contract, which has an ultimate completion date of April 12, 2024, was awarded on April 11, 2024 by the Defense Logistics Agency (DLA), a defense...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSCCEDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,461.70 to AmerisourceBergen Drug Corp for the supply of Zonisade 100 mg/5 ml oral suspension in a 150 ml quantity. This firm fixed-price delivery order, awarded on August 4, 2025, with an ultimate completion date of August 5, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated as SPE2DX. The contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company holds a $999,999,999.00 IDC with DLA Troop Support Medical through December 2026, which enables the supply of a comprehensive range of pharmaceutical products, medical devices, vaccines, and specialized healthcare commodities to support Defense Health Agency and U.S. Coast Guard operations. This specific delivery order for Zonisade reflects the company's ongoing role in fulfilling pharmaceutical supply requirements across the federal healthcare system through flexible contract vehicles.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 8/4/25 |